Identification and characterization of candidate therapeutic targets in acute myeloid leukemia

Medicine and Dentistry

• Therapeutics 100%
• Leukemia Cell 60%
• Therapeutic Procedure 15%
• Stimulation 15%
• Cytokine 15%
• Programmed Cell Death 15%
• Patient 10%
• Ex Vivo 10%
• Toll Like Receptor 2 10%
• Disease 5%
• NPM1 5%
• Transplantation 5%
• Overall Survival 5%
• Chemotherapy 5%
• Bone Marrow 5%
• Prognosis 5%
• Myeloid Cell 5%
• Short Hairpin RNA 5%
• Cell Surface Protein 5%
• p38 Mitogen-Activated Protein Kinase 5%
• Stem Cell 5%

Immunology and Microbiology

• Leukemia Cell 54%
• TLR2 9%
• Transplant Procedure 4%
• Cell Surface 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Leukemia 35%
• Apoptosis 15%
• Prognosis 5%
• Chemotherapy 5%
• High-Throughput Screening 5%